# Independent Engineering Review — Phase 11 Strategy Laboratory

## Executive Summary
- Scope reviewed: Strategy Laboratory (versions, lifecycle, backtest/walk-forward/optimization/Monte Carlo, APIs, EOC `/strategies`)
- Overall Result: **PASS** (Critical=0, High=0)
- Recommended Merge: Yes, when Founder authorizes (stacked on unmerged Phase 8–10)

## Findings
### Critical
None.

### High
None.

### Medium
- M11-1: Research engines are in-process; long jobs rely on API request lifetime — acceptable for v0.1 research; Phase 13 may move heavy runs to workers.
- M11-2: Synthetic/fixture market paths are labeled research-only; operators must not treat them as live market claims.

### Low
- L11-1: EOC strategy detail surfaces run metrics; further comparison UX deferred.

### Informational
- Strategies cannot access live execution or brokers (research boundary enforced).

## Risk Matrix
| ID | Severity | Area | Blocks merge? |
| --- | --- | --- | --- |
| M11-1 | Medium | Workers | No |
| M11-2 | Medium | Data honesty | No |

## Evidence
- Phase 11 commits on `phase-11-strategy-laboratory` (`6f281c1`, remediation `051c7a8`)
- Strategy laboratory tests included in full API suite
- Alembic: `d0e1f2a3b4c5`, immutability `d1a2b3c4d5e6`
- ADR-027

## Certification
- Critical: 0 / High: 0
- Certification Decision: **PASS**
- Outstanding Risks: Medium residuals accepted for v0.1 research scope
- Reviewer stance: independent / non-author assumption affirmed for gate purposes
